The incidence and time course of the immune response to Vero toxin -producing Escherichia coli (VTEC) other than 0157 (026, 055, 0111, 0128) were determined in to7 children with enteropathic hemolytic uremic syndrome (HUS) by ELISA and compared to antibody profiles of 125 healthy pediatric controls and toO children with community-acquired uncomplicated diarrhea. Six of 8 HUS patients with non-0157 VTEC isolates exhibited a serologic response to the homologous lipopolysaccharide antigen similar to that of patients infected with E. coli 0157. In addition, elevated IgM or IgG antibodies were demonstrated in 7 of 19 culture-and 0157 serology-negative HUS patients. Serogroup-specific antibodies decreased below cutoff levels within several months after convalescence. Anti-non-0157 antibodies were found in 14% of the diarrheic controls. Unexpectedly, a high proportion (27/82) of anti-0157 lipopolysaccharide antibody-positive HUS samples reacted with LPS from E. coli 055:B5, suggesting shared epitopes with endemic VTEC 0157 strains.
The incidence and time course of the immune response to Vero toxin -producing Escherichia coli (VTEC) other than 0157 (026, 055, 0111, 0128) were determined in to7 children with enteropathic hemolytic uremic syndrome (HUS) by ELISA and compared to antibody profiles of 125 healthy pediatric controls and toO children with community-acquired uncomplicated diarrhea. Six of 8 HUS patients with non-0157 VTEC isolates exhibited a serologic response to the homologous lipopolysaccharide antigen similar to that of patients infected with E. coli 0157. In addition, elevated IgM or IgG antibodies were demonstrated in 7 of 19 culture-and 0157 serology-negative HUS patients. Serogroup-specific antibodies decreased below cutoff levels within several months after convalescence. Anti-non-0157 antibodies were found in 14% of the diarrheic controls. Unexpectedly, a high proportion (27/82) of anti-0157 lipopolysaccharide antibody-positive HUS samples reacted with LPS from E. coli 055:B5, suggesting shared epitopes with endemic VTEC 0157 strains.
Escherichia coli capable of producing Vero toxins (Shiga toxins) belong to multiple serovars [1 -3] . E. coli 0157:H7 is the predominant cause of hemorrhagic colitis and the enteropathic hemolytic uremic syndrome (E+ HUS) [1, 2] . However, at least 57 additional Vero toxin-producing E. coli (VTEC) serovars belonging to 34 different 0 groups have been isolated from humans [1, 4] . The relative pathogenic and epidemiologic importance of non-O 157 VTEC strains as the cause of HUS has been debated [2, 3, 5] . Recent outbreaks by non-Ol57 VTEC strains [6] [7] [8] [9] [10] [11] and a higher incidence of infections by non-0157 VTEC relative to E. coli 0157:H7 in some geographic areas [7, [12] [13] [14] [15] [16] [17] emphasize the need for efficient diagnostic techniques and a better understanding of the epidemiology of and immune response to non-Ol57 VTEC infections.
Isolation of non-O 157 VTEC strains remains a challenge. Most non-O 157 VTEC ferment sorbitol during overnight incubation and will be missed when using selective media, such as sorbitol MacConkey agar. Similarly, the immunomagnetic separation technique using beads coated with antibody to E. coli 0157 [18] fails to identify non-O 157 VTEC. Sensitive cytotoxicity assays [1] and molecular biology techniques based on the detection of Vero toxin genes, such as colony blot hybridization and polymerase chain reaction screening of stools or large numbers of isolates, may increase the diagnostic yield, but these methods are too cumbersome for routine microbiologic evaluation of stools. Rapid elimination of VTEC from the gut after the onset of HUS may further thwart their isolation [1, 19, 20] . The evaluation of appropriate serologic techniques for the diagnosis of non-0157 VTEC infections is therefore warranted.
The detection of Vero toxin -specific antibodies is hampered by low sensitivity [21] [22] [23] [24] [25] . Infection by VTEC 0157:H7 can be reliably detected using lipopolysaccharide (LPS)-based antibody tests [15, 21, [24] [25] [26] [27] [28] [29] . To improve the diagnosis of non-0157 VTEC infection, attempts to detect antibodies against VTEC 0 groups other than 0157 have been reported [6, 15, 25, [28] [29] [30] [31] [32] [33] [34] . For example, the demonstration of serogroup-specific antibodies allowed the recognition of a VTEC Olll-associated outbreak of HUS in northern Italy [6] . Little is known, however, about the sensitivity and specificity of these assays for the detection of antibodies to non-O 157 VTEC or about the occurrence of antibodies to non-O 157 VTEC in the healthy population.
The objective of the present study was to establish immunoglobulin class-specific ELISAs for the detection ofnon-0157 LPS antibodies and to evaluate their applicability to diagnosis. Specifically, we sought to determine if patients with E+ HUS caused by non-0157 VTEC serogroups develop a measurable o group-specific immune response similar to that to 0157 LPS and whether testing with a select panel of LPS antigens would be useful. After defining the spectrum of ELISA reactivi- coli. Sera were from various parts of Germany (with few patient samples from Switzerland, Austria, and France (AIsace). Group 1, ambulatory patients or children for elective surgery who had no history of HUS or recent diarrhea; group 4, community-acquired acute diarrhea without contact to HUS patients or proven VTEC infection. Stool specimens (no. positive in parentheses) were routinely screened for Salmonella (33) , Shigella (2), Yersinia (1), and Campylobacter (1) species, and in infants, rotavirus (18) and adenovirus (2) and traditional enteropathogenic E. coli (4 ties in a large pediatric population of healthy subjects, we analyzed the magnitude, immunoglobulin class, and kinetics of the antibody response and compared it with the immune response to E. coli 0157, using sera of children with HUS and with uncomplicated diarrhea.
Materials and Methods
Patient sera. Pertinent clinical, microbiologic, and demographic data are listed in table 1. Briefly, sera from 8 patients with classical (E+) HUS that was associated with fecal VTEC isolates belonging to serogroups other than 0157 were examined (group 2). These patients (l0 months to 22 years old; median, 1.6 years) were from Germany (n = 6) and Switzerland (n = 2). They were identified between 1983 and 1994 and were not linked epidemiologically. In addition, serum samples of 99 E+ HUS patients with negative stool cultures for VTEC, diagnosed between 1985 and 1993, were investigated (group 3).
Control sera. Samples were obtained from 125 well children of all pediatric age groups who had no history of HUS or recent diarrhea (group 1) and from 100 children with uncomplicated, acute diarrhea who had not been in contact with HUS patients (group 4). The majority of the control sera were obtained during the summer and fall to reflect the seasonal variation of the E+ HUS. All controls and most of the HUS patients were from Germany. A pooled human plasma preparation containing physiologic concentrations of the major immunoglobulin classes (Biseko; Biotest Pharma, Dreieich, Germany) and an intravenous IgA-and IgMenriched immunoglobulin preparation (Pentaglobin; Biotest Pharma) were used as additional controls. All serum samples were aliquoted and stored at -20°C until use.
Stool samples. Stools from HUS patients were examined for VTEC and other common enteropathogenic bacteria within the first 1 or 2 weeks after onset ofHUS as described [28, 35] . Studies included slide agglutination of at least 5 lactose-fermenting colonies with E. coli 0157, and typing sera for the traditional enteropathogenic E. coli (EPEC) 0 antigens [36] , growth on sorbitolMacConkey agar, and cytotoxicity assays. E. coli isolates were characterized biochemically and serologically, and their Vero toxin profile was determined. Stool samples of the diarrheic controls obtained on admission to hospital were routinely screened for Salmonella, Shigella, and Campylobacter species and Yersinia enterocolitica and in some instances for gastrointestinal viruses. In addition, 65 samples were also screened for traditional EPEC strains as described above but only occasionally for Vero toxin-producing E. coli (microbiologic results of group 2 and group 4 patients are summarized in the footnote to ) . The E. coli 0157:H-strain 493-1, originally isolated from a patient with HUS, was grown in yeast extract medium, and the LPS was extracted as described [22, 37] . All LPS preparations were separated by SDS-PAGE and visualized by silver staining [38] and immunoblotting [39] , confirming the smoothness and serogroup specificity of the LPS used for the ELISA. No protein contamination was detected after staining with Coomassie blue.
SDS-PAGE and immunoblotting. LPS (6 ,Ltg/lane) was analyzed by electrophoresis in 11% (wt/vol) polyacrylamide gels using a minigel apparatus (Mini-Protean II electrophoresis cell; BioRad Laboratories, Richmond, CA). Replicate gels were fixed and stained with Coomassie or silver stain, respectively [38] . Separated LPS was electroblotted onto nitrocellulose (Schleicher & Schull, Berlin) for 1 h as described [39] . Unreacted sites on the nitrocellulose were blocked with PBS containing 0.05% Tween 20 (PBS-T; Merck, Darmstadt, Germany), followed by washing and overnight incubation with human sera diluted 1:100 or rabbit antibody diluted 1:5000 in PBS-To Bound immunoglobulin was detected using alkaline phosphatase-conjugated rabbit anti-human IgA, IgM, or IgG (heavy chain-specific) or goat anti-rabbit IgG (all from Sigma). The conjugate antibody was diluted between 1:1000 and 1:1500 according to the manufacturer's specifications. Indoylphosphate and nitroblue tetrazolium (Sigma) were used as substrates.
IPS-based ELISA. Flat-bottom, 96-well ELISA plates (Immunoplates MaxiSorb; Nunc, Roskilde, Denmark) were coated with optimal amounts of each LPS (0.1-1 ,Ltg/well) dissolved in 0.05 mL of 0.01 M PBS, pH 7.4, dried overnight at 37°C, washed six times with PBS containing 1% Tween, and used immediately or stored for up to 12 months at room temperature without demonstrable loss of activity. Human or rabbit serum, 0.1 mL diluted with PBS containing 0.1% Tween and 2% fetal calf serum (Boehringer Mannheim, Mannheim, Germany), was added per well and incubated at 37°C. Patient and control sera were tested in triplicate. Bound immunoglobulins were detected using alkaline phosphatase-conjugated rabbit anti-human IgA, IgM, or IgG (heavy 
Specificity and sensitivity of LPS ELISAs.
Rabbit immune sera demonstrated high IgG antibody levels against homologous LPS, while the pool A serum reacted with all non-Ol57 LPS. No appreciable cross-reactions were observed with heterologous LPS from selected EPEC 0 groups or with LPS from the E. coli 0157:H-isolate. Using human sera, titration curves were established with all ELISAs. Patient sera were clearly separated from control samples over the entire range of dilutions. The resolution was highest in the range of 11400 to 11 2000. For the IgA and IgM ELISAs, acute patient sera revealed 20-to 50-fold greater titers than the controls (figure 1). Distribution ofnon-0157 VTEC LPS ELISA reactivities in the control population (group 1). Control sera obtained from children without a history of recent gastrointestinal illness were investigated by ELISA for their reactivity with LPS from four EPEC serogroups using heavy chain-specific conjugate antibodies against human IgA, IgM, and IgG. IgM and IgG reactivities to E. coli 026, 055, 0111, and 0128 LPS are shown in Results chain-specific) or goat anti-rabbit IgG (both Sigma). The conjugate antibody dilutions (l: 1000-1: 6000) were standardized with each lot and for each ELISA using defined positive and negative controls; p-nitrophenyl phosphate (SigmaFast; Sigma) was used as substrate. The enzymatic reaction was stopped after 30 min at 37°C with I M NaOH. The optical density was recorded at 405 nm against a blank well containing substrate solution and NaOH. The results were expressed as ELISA units (A 405 X 10 3 ) . Based on previous studies [22] and titration experiments (figure 1), a dilution of I :500 was chosen for all human and rabbit sera (primary antibody) except when indicated otherwise. Results were confirmed in most instances by at least two separate assays. The serum of a healthy blood donor and the immunoglobulin-containing plasma products Biseko and Pentaglobin were run on each plate as internal controls. The interassay variability was generally <20%. LPS coating efficiency and antigen stability were ascertained by the inclusion of homologous and heterologous rabbit immune sera with each assay.
Break points were established using the sera of 125 healthy controls. For each LPS antigen and immunoglobulin class, the optical densities (ODs) of triplicate measurements of each control serum were averaged and SDs calculated. An OD value above the arithmetic mean + 3 SD, derived from the control population for the respective assay, was considered positive. The serologic diagnosis was based on IgM and/or IgG assay readings. Sole IgA reactivity above the cutoff was not considered diagnostically conclusive (see Results).
Statistical analysis. Data were processed using Excel 5.0 (Microsoft, Redmond, WA) and Cricket Graph 1.3 (Cricket Software, Malvern, PA). Data were expressed as arithmetic mean values of OD readings (ELISA units) or as multiples ofSDs above the mean. For statistical analysis and assessment of the means, t tests with appropriate corrections were used [40] . The level of significance was set at P < .05. .. figure 2. We observed a slight trend towards greater ELISA units with increasing age of the donor; however, the differences of the arithmetic means of the OD values between the younger and older children (cutoff, 10 years) did not reach significance (P > .05 for all assays). The highest ELISA reactivities in the control group were demonstrated with the 0 III LPS IgG assay. Mean IgG ELISA values for various LPS antigens differed significantly (P < .01). In contrast, no significant differences were found for IgA and IgM (P > .05 for all assays). The break points derived from these controls were applied to the analysis of patient sera. Eight controls had IgM and/or IgG antibodies above the respective cutoffs. Four of them reacted with more than one LPS antigen. Their antibody levels were generally only slightly above the break point (see figure 2) .
LPS-specijic antibodies in HUS patients with non-O157 VTEC isolates (group 2). Acute serum samples of 8 HUS patients with VTEC isolates other than serogroup 0157, namely 026,055, and 0111, were examined for the presence of antibodies against LPS derived from homologous and heterologous E. coli serogroups. The level of antibodies detected by ELISA varied among patients and associated VTEC serogroups: All 5 patients with VTEC 026 or 055 isolates had elevated IgA, IgM, and IgG antibodies (acute and/or convalescent sera) against the homologous LPS. In contrast, 2 of 3 patients with VTEC 0111 isolates lacked a detectable immune response, while only low-titer antibodies of the IgM (and IgA) class were detected in the third patient (table 2). In comparison, 19 of 20 HUS patients with E. coli 0157:H7 or 0157:Hisolates exhibited diagnostic anti -0157 LPS antibodies (unpublished data). ELISA results were in complete agreement with immunoblot results; that is, all ELISA-positive sera were positive by immunoblot, while the 2 ELISA-negative sera from patients with VTEC 0111 isolates were also negative by immunob lot (results not shown).
To determine the serogroup specificity of the LPS ELISAs and their diagnostic validity using patient sera, samples of all 8 group 2 patients were tested with a panel of heterologous LPS antigens, including 0157 LPS. The serum of a patient with a VTEC 026:H-isolate (patient 3) reacted with multiple LPS antigens; the serum of a patient with a VTEC 0111 isolate (patient 7) showed weak positive reactions in the 0111 and the 026 LPS ELISA (both IgM). None of the remaining sera reacted with heterologous LPS (table 2). A synopsis of the immune responses is shown in figure 3 . For easier comparison, ELISA results were expressed as multiples of the SDs (SD units) above the mean of the pediatric control sera. Note that bars are invisible because of scale at low ELISA reactivities (~l SD above the mean of healthy controls); that is, no bars indicate negative results.
BUS patients without VTEC isolate (group 3)
. Serum samples from 99 HUS patients from whom VTEC isolates had not been recovered were examined for antibodies of all three immunoglobulin classes to 026, 055, 0111, 0128, and 0157 LPS by ELISA. Eighty-five of the 99 patients had IgA, IgM, or IgG antibodies above the cutoff level. Three of the 85 samples reacted only in IgA ELISAs. Mean and range of anti-0157 LPS antibody levels of the remaining 82 samples were similar to those of patients with microbiologically proven VTEC 0157 infection (data not shown).
Of the 17 HUS patients lacking IgM and/or IgG antibodies to 0157 LPS, 8 reacted with one or more of the non-O157 antigens tested. A single sample was positive only in the IgA ELISA (0111 LPS), while the remaining 7 patients exhibited IgM and/ or IgG antibodies against non-0157 antigens (41% of the anti-0157 antibody-negative patients): 026, 3 patients; 055, 0111, 0128, 026, and 055, 1 each (table 3). The acute-phase serum was diagnosticin 6 ofthese patients, and the other became positive during convalescence (anti-026 and -055 LPS IgG, patient 11). The magnitude of the immune response of the 7 non-0157 LPS antibody-positive patients is shown in figure 4 . Based on our observation that IgA ELISA results were occasionally positive (i.e., above the cutoff level) without detectable homologous IgM or IgG antibodies, sole IgA reactivities were not considered diagnostic. Data are summarized in 
HUS patients
frequency of antibodies to 055 LPS was low in HUS patients with microbiologically confirmed non-0157 E. coli infection (group 2), which is in keeping with the frequency of VTEC 055 isolates in this group (table 2, figure 3 ). Moreover, onethird of HUS patients with 0157 isolates also had antibodies to 055 LPS (unpublished data), indicating shared epitopes between EPEC 055:B5 and endemic VTEC 0157 strains.
To explore the potential importance of antibodies to non-0157 VTEC serovars, especially in patients with multiple reactivities, antibody levels to non-O 157 antigens were directly plotted against antibody levels to 0157 LPS. Examples are shown in figure 5 . No correlation was observed between anti-026 and anti-O 157 reactivities. This indicates that high antibody levels to 026 LPS, and similarly to 0111 and 0128 LPS (data not shown), result from specific immunologic stimulation. In contrast, increased 055 LPS ELISA reactivities corresponded to elevated 0157 LPS antibody levels, suggestive of cross-reactivity (figure 5).
Control patients with uncomplicated diarrhea (group 4). Sera of 100 children with acute diarrhea who had no contact with HUS patients or cases of proven or suspected VTEC infection were examined to assess the incidence of non-0157 LPS antibodies in patients with uncomplicated gastrointestinal illnesses. Fourteen percent tested positive for one (n = 10) or more (n = 4) E. coli serogroups as defined by the detection of elevated IgM and/or IgO antibodies (026 > 055 = 0128 > 0111). The sera of 3 additional patients reacted only in the IgA ELISA. Two patients had low-level IgO antibodies against the 0157 LPS. Traditional EPEC strains were isolated from 4 children, namely serogroups 026, 0119 from 2, and 0125. The infant with EPEC 026 diarrhea revealed a strong serogroupspecific immune response pertinent to all three immunoglobulin classes, while sera of the remainder did not react with any of the heterologous LPS antigens tested.
Kinetics of anti-Ll'S antibodies. During convalescence, a rapid decline in IgA and IgM antibodies to non-O 157 LPS was documented in most patients with appropriate follow-up samples. A transient rise of IgG antibodies was observed in 3 of 6 patients during the acute or postacute phase. The few cases with late samples revealed a decrease in anti-LPS NOTE. Sera from 82 HUS patients without Vero toxin-producing E. coli isolates had serologic evidence of E. coli 0157 infection (elevated IgM and/or IgG anti-0l57 LPS antibodies by ELISA). Sera from 33 reacted with 1 (n = 29) or multiple (n = 4) non-0157 LPS antigens.
* Some samples were positive in > 1 ELISA.
t Results are given as fold SDs above mean of healthy pediatric control group. Break points were set at 3SD above mean for each LPS antigen and immunoglobulin class. IgG antibodies below the cutoff level within several months (figure 6).
Discussion
In the present study, we systematically analyzed the humoral immune response of pediatric HUS patients to a panel of non-0157 VTEC serogroups by ELISA. In addition, the incidence of antibodies to the same antigens was examined in children with uncomplicated diarrhea. Since the prevalence of antibodies to E. coli 026, 055, 0111, and 0128 in our population was not known, we also screened control sera of all pediatric age groups. Results derived from the control population suggest the presence of IgG antibodies to 0 III LPS with a trend toward increasing levels with age. IgG levels to the remaining 0 antigens, including 0157, were considerably lower, while no LPS type-related differences were observed with the IgM ELISAs. This may reflect varied past exposures to homologous or crossreactive bacterial epitopes associated with a lasting IgG response to some LPS antigens in the population studied. Of interest, using an indirect hemagglutination technique, Neter et al. [41] reported 40 years ago that healthy individuals had higher antibody titers with increasing age against common EPEC 0 antigens.
Few studies have addressed the frequency of non-0157 VTEC isolates from HUS patients [15, 22, 42, 43] or from patients with VTEC-associated diarrhea [5, 7, 12, [44] [45] [46] . In our continuing study of the role of Vero toxin-producing E. coli in pediatric HUS in Germany, overall slightly < 10% of the HUS patients had evidence by bacterial isolation and/or LPS serology of non-O 157 VTEC infection, with 026 being the most common serogroup (unpublished data). Serologic results presented in this study accord with the incidence of the implicated non-OI57 VTEC serovars.
Our data indicate that patients with HUS associated with infection by non-OI57 VTEC strains can develop a robust, 0 group-specific immune response similar to patients with E. coli 0157:H7 infection. We detected homologous antibodies in sera of 6 of 8 HUS patients with non-OI57 VTEC isolates. Subsequently, 7 of 17 VTEC culture-and 0157 LPS antibody-negative patients were found to possess elevated antibodies to non-O 157 LPS. In the absence of an immune response to 0157 LPS, detection of high antibody levels to non-O 157 LPS strongly suggests recent infection by corresponding E. coli serovars. Thus, a probable serologic diagnosis was possible in 41% of formerly undiagnosed patients using this panel of LPS ELISAs.
However, we failed to detect an appropriate antibody response in 2 of the 3 patients with fecal VTEC 0111 isolates. In contrast, serum from another patient with a Vero toxinproducing 026:Hll isolate reacted strongly with 026 and 0157 LPS and, to a lesser extent, with 055, 0111, and 0128 LPS (patient 3, figure 3 ). These examples raise the possibility that a Vero toxin-producing strain, isolated during acute HUS, may not be the disease-causing agent. Indeed, isolation of differing VTEC serovars from the same patient, including E. coli 0157, has been reported [7, 45, 47] . While E. coli 026:Hl1, 026:H-, and other non-0157 VTEC strains have clearly been implicated in the pathogenesis ofHUS [1,2], their relative role in the individual patient concomitantly infected with E. coli 0157 is difficult to assess.
This study confirms earlier results demonstrating that the majority of E + HUS patients have elevated or rising antibody levels to E. coli 0157 LPS [21, 24, 25, 27, 28] . However, more than one-third of the sera reacted with additional LPS antigens (see table 3 ). The vast majority of these samples had antibodies to 055 LPS derived from EPEC 055:B5 in addition to antibodies to 0157. E. coli 0157:H7 can cause severe colonic inflammation [48, 49] . Increased mucosal permeability allows anti- [50] , potentially leading to spurious serologic results. This might be at work with antibodies to other VTEC serogroups in some patients with bona fide E. coli 0157 infection. However, the high incidence of anti-055 LPS antibodies in this group suggests it is a specific cross-reaction. We corroborated this observation by examining the sera of20 HUS patients with microbiologically confirmed E. coli 0157 infection. Of these patients, 19 had elevated anti-0157 LPS antibodies; 37% of them reacted also with 055 LPS (unpublished data). This serologic relationship, illustrated in figure 5 , was unexpected, since crossreactions between 055 and 0157 LPS have not been described previously [36, 51, 52] . Notably, no cross-reactions were observed with rabbit standard agglutination sera or the serum samples of the 2 patients with VTEC 055:H-and 055:H6 isolates, respectively (figure 3, patients 4 and 5). Serologic differences, for example, between clinical VTEC 055 isolates and the strains used for the production of the typing sera and of the LPS used in our ELISA may be important [53] .
The observation that sera from patients with E. coli 0157 infection react with the 055 LPS is interesting in view of the close genetic relationship between VTEC 0157:H7 and EPEC 055:H7, an E. coli strain associated with worldwide outbreaks of infantile diarrhea [54] . Other E. coli 055 strains, particularly 055:H6 and 055:H-, are genetically much more diverse and not necessarily closely related to EPEC 055:H7 [54] . E. coli 0157:H7 differs from E. coli 055:H7 by only one electromorph, that of 6-phosphogluconate dehydrogenase (6PGD; EC 1.1.1.44), which is encoded by the gnd locus (55] . In E. coli, gnd is adjacent to the rfb cluster [56] , which encodes the enzymes necessary for the synthesis of the unique antigenic 0 side chain component of LPS. Whittam [55] suggested that the ancestral 055:H7 clone experienced a recombination event involving part or all of gnd and the contiguous rfb cluster, resulting in an organism with a different 6PGD electromorph and 0 antigen. Our data indicate that some epitopes remain identical between the E. coli 0157 and E. coli 055 0 side chains, suggesting that some sequences of the rfb cluster may be preserved in the two serovars.
Diarrhea from EPEC can induce an 0 group-specific immune response [41, 57, 58] , also shown in this study (group 4) . The discrepancy between the frequency of elevated anti-
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is possible that the low frequency of VTEC-associated HUS observed in less-developed countries or among lower socioeconomic classes [12, 14, [60] [61] [62] is the result of 0 groupspecific or cross-reactive (mucosal) immunity acquired during infancy.
In conclusion, we provide additional evidence that non-O 157 VTEC strains are associated with classical childhood HUS and that they can induce a strong antibody response against outer membrane components of the organism. Future studies are needed to firmly establish the utility of LPS-based serologic techniques for the acute and retrospective diagnosis of non-0157 VTEC infections. Elucidation of cross-reactions between o antigens from related VTEC and EPEC clones may improve the interpretation of serologic results and offer insight into the evolution of these "new" pathogens, which are increasingly recognized as causes of outbreaks of diarrhea and HUS in various parts of the world. LPS antibodies and the frequency of EPEC or VTEC isolates in the diarrheic control group may be explained by the fact that only about two-thirds of the stool samples were screened for these pathogens. Other confounders are the lack of sensitivity of traditional EPEC screening methods and, possibly, discontinuation of bacterial shedding at the time of specimen sampling. In addition, 50% of the serum samples were positive for IgG only, which may indicate past infection unrelated to the cause of diarrhea at the time when the serum was collected. Alternatively, cross-reactions with other enteropathogens may occur [52, 59] . Careful studies with more sensitive identification techniques are needed to reconcile these findings. The intriguing question, whether previous exposure to certain EPEC strains protects against infections by corresponding VTEC serogroups, remains to be evaluated. For example, it
